3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2023

Overview

Journal Diabetes Care

Specialty Endocrinology

Date 2022 Dec 12

PMID 36507633

Authors

Nuha A ElSayed

Grazia Aleppo

Vanita R Aroda

Raveendhara R Bannuru

Florence M Brown

Dennis Bruemmer

Billy S Collins

Marisa E Hilliard

Diana Isaacs

Eric L Johnson

Scott Kahan

Kamlesh Khunti

Jose Leon

Sarah K Lyons

Mary Lou Perry

Priya Prahalad

Richard E Pratley

Jane Jeffrie Seley

Robert C Stanton

Robert A Gabbay

the American Diabetes Association

Affiliations

Soon will be listed here.

Abstract

The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

Citing Articles

Disparities in Antidiabetic Medication Discontinuation Between Non-Hispanic White and Black Beneficiaries in Medicare Across Diabetes Belt and Surrounding Area.

Zhang P, Lobo J, Sohn M, Balkrishnan R, Anderson R, McCall A J Racial Ethn Health Disparities. 2025; .

PMID: 40088385 DOI: 10.1007/s40615-025-02388-8.

What are end-users' needs and preferences for a comprehensive e-health program for type 2 diabetes? - A qualitative user preference study.

Rishaug T, Aas A, Henriksen A, Hartvigsen G, Birkeland K, Arsand E PLoS One. 2025; 20(3):e0318876.

PMID: 40029895 PMC: 11875348. DOI: 10.1371/journal.pone.0318876.

Genetic Variants of rs628031 and rs622342 and Glycemic Control in T2DM Patients from Northern Mexico.

Moreno-Gonzalez J, Reza-Lopez S, Gonzalez-Rodriguez E, Siqueiros-Cendon T, Escareno Contreras A, Rascon-Cruz Q Genes (Basel). 2025; 16(2).

PMID: 40004467 PMC: 11855146. DOI: 10.3390/genes16020139.

High-Intensity Interval Training for Individuals With Isolated Impaired Fasting Glucose: Protocol for a Proof-of-Concept Randomized Controlled Trial.

Thirunavukkarasu S, Ziegler T, Weber M, Staimez L, Lobelo F, Millard-Stafford M JMIR Res Protoc. 2025; 14:e59842.

PMID: 39977858 PMC: 11888011. DOI: 10.2196/59842.

Effect of broccoli sprout extract and baseline gut microbiota on fasting blood glucose in prediabetes: a randomized, placebo-controlled trial.

Dwibedi C, Axelsson A, Abrahamsson B, Fahey J, Asplund O, Hansson O Nat Microbiol. 2025; 10(3):681-693.

PMID: 39929977 PMC: 11879859. DOI: 10.1038/s41564-025-01932-w.

References

de Jager J, Kooy A, Lehert P, Wulffele M, van der Kolk J, Bets D . Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ. 2010; 340:c2181. PMC: 2874129. DOI: 10.1136/bmj.c2181. View

Kim S, Castro Sweet C, Cho E, Tsai J, Cousineau M . Evaluation of a Digital Diabetes Prevention Program Adapted for Low-Income Patients, 2016-2018. Prev Chronic Dis. 2019; 16:E155. PMC: 6896833. DOI: 10.5888/pcd16.190156. View

. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002; 25(12):2165-71. PMC: 1282458. DOI: 10.2337/diacare.25.12.2165. View

Cai T, Abel L, Langford O, Monaghan G, Aronson J, Stevens R . Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses. BMJ. 2021; 374:n1537. PMC: 8279037. DOI: 10.1136/bmj.n1537. View

Raynor H, Davidson P, Burns H, Nadelson M, Mesznik S, Uhley V . Medical Nutrition Therapy and Weight Loss Questions for the Evidence Analysis Library Prevention of Type 2 Diabetes Project: Systematic Reviews. J Acad Nutr Diet. 2017; 117(10):1578-1611. DOI: 10.1016/j.jand.2017.06.361. View

Bosch J, Yusuf S, Gerstein H, Pogue J, Sheridan P, Dagenais G . Effect of ramipril on the incidence of diabetes. N Engl J Med. 2006; 355(15):1551-62. DOI: 10.1056/NEJMoa065061. View

Gong Q, Gregg E, Wang J, An Y, Zhang P, Yang W . Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia. 2010; 54(2):300-7. DOI: 10.1007/s00125-010-1948-9. View

Spence J, Viscoli C, Kernan W, Young L, Furie K, DeFronzo R . Efficacy of lower doses of pioglitazone after stroke or transient ischaemic attack in patients with insulin resistance. Diabetes Obes Metab. 2022; 24(6):1150-1158. DOI: 10.1111/dom.14687. View

Thakker D, Nair S, Pagada A, Jamdade V, Malik A . Statin use and the risk of developing diabetes: a network meta-analysis. Pharmacoepidemiol Drug Saf. 2016; 25(10):1131-1149. DOI: 10.1002/pds.4020. View

10.

Hamman R, Wing R, Edelstein S, Lachin J, Bray G, Delahanty L . Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006; 29(9):2102-7. PMC: 1762038. DOI: 10.2337/dc06-0560. View

11.

Ali M, Bullard K, Saydah S, Imperatore G, Gregg E . Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014. Lancet Diabetes Endocrinol. 2018; 6(5):392-403. PMC: 6615033. DOI: 10.1016/S2213-8587(18)30027-5. View

12.

Fischer H, Durfee M, Raghunath S, Ritchie N . Short Message Service Text Message Support for Weight Loss in Patients With Prediabetes: Pragmatic Trial. JMIR Diabetes. 2019; 4(2):e12985. PMC: 6487341. DOI: 10.2196/12985. View

13.

. Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 2012; 35(4):731-7. PMC: 3308305. DOI: 10.2337/dc11-1299. View

14.

Alva M, Hoerger T, Jeyaraman R, Amico P, Rojas-Smith L . Impact Of The YMCA Of The USA Diabetes Prevention Program On Medicare Spending And Utilization. Health Aff (Millwood). 2017; 36(3):417-424. DOI: 10.1377/hlthaff.2016.1307. View

15.

Li G, Zhang P, Wang J, An Y, Gong Q, Gregg E . Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol. 2014; 2(6):474-80. DOI: 10.1016/S2213-8587(14)70057-9. View

16.

Pittas A, Dawson-Hughes B, Sheehan P, Ware J, Knowler W, Aroda V . Vitamin D Supplementation and Prevention of Type 2 Diabetes. N Engl J Med. 2019; 381(6):520-530. PMC: 6993875. DOI: 10.1056/NEJMoa1900906. View

17.

Chiuve S, Fung T, Rimm E, Hu F, McCullough M, Wang M . Alternative dietary indices both strongly predict risk of chronic disease. J Nutr. 2012; 142(6):1009-18. PMC: 3738221. DOI: 10.3945/jn.111.157222. View

18.

Preiss D, Seshasai S, Welsh P, Murphy S, Ho J, Waters D . Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA. 2011; 305(24):2556-64. DOI: 10.1001/jama.2011.860. View

19.

Spence J, Viscoli C, Inzucchi S, Dearborn-Tomazos J, Ford G, Gorman M . Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial. JAMA Neurol. 2019; 76(5):526-535. PMC: 6515584. DOI: 10.1001/jamaneurol.2019.0079. View

20.

Cannon M, Masalovich S, Ng B, Soler R, Jabrah R, Ely E . Retention Among Participants in the National Diabetes Prevention Program Lifestyle Change Program, 2012-2017. Diabetes Care. 2020; 43(9):2042-2049. PMC: 11000538. DOI: 10.2337/dc19-2366. View